| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/30/2002 | US6379550 Chromatography |
| 04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 04/30/2002 | CA2176929C Vaccine against mumps containing a jeryl-lynn virus strain |
| 04/30/2002 | CA2147162C Remyelination using neural stem cells |
| 04/30/2002 | CA2128784C Large, latent complexes of tgf-beta2 and tgf-beta3 |
| 04/30/2002 | CA2093819C Platelet adhesion inhibitor |
| 04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
| 04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
| 04/30/2002 | CA2054111C Novel inhibitory peptides |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/27/2002 | CA2360015A1 Angiotensin i-converting enzyme inhibitory substance |
| 04/27/2002 | CA2321944A1 Enhancement of freezing tolerance in transgenic strawberry |
| 04/25/2002 | WO2002033416A1 Assays |
| 04/25/2002 | WO2002033406A1 New nmr screening method |
| 04/25/2002 | WO2002033376A2 Polypeptides inhibiting hepatitis c virus internal ribosome entry site (ires), and method for screening said polypeptides |
| 04/25/2002 | WO2002033129A2 Nucleic acid amplification controls |
| 04/25/2002 | WO2002033124A1 KChAP-MODULATOR OF POTASSIUM CHANNELS |
| 04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | WO2002033116A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | WO2002033115A2 Claspin proteins and methods of use thereof |
| 04/25/2002 | WO2002033114A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033113A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033112A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033111A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 04/25/2002 | WO2002033107A2 Plant cell death system |
| 04/25/2002 | WO2002033106A2 Plant cell death system |
| 04/25/2002 | WO2002033104A2 Antibiotic-based gene regulation system |
| 04/25/2002 | WO2002033103A2 Non-human mammal with modified pacap type i receptor |
| 04/25/2002 | WO2002033102A1 Receptor mediated activation of heterotrimeric g-proteins |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033092A1 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 04/25/2002 | WO2002033091A1 Manipulation of flowering and plant architecture |
| 04/25/2002 | WO2002033090A2 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/25/2002 | WO2002033089A2 Ixodes scapularis tissue factor pathway inhibitor |
| 04/25/2002 | WO2002033088A2 Human carboxypeptidase, scramblase, and protocadherin family members and uses thereof |
| 04/25/2002 | WO2002033087A2 Proteins and nucleic acids encoding same |
| 04/25/2002 | WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2002033085A2 Wisp polypeptides and therapeutical applications thereof |
| 04/25/2002 | WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family |
| 04/25/2002 | WO2002033083A2 Methods of using a human il-17-related polypeptide to treat disease |
| 04/25/2002 | WO2002033082A1 Novel disease-associated gene and use thereof |
| 04/25/2002 | WO2002033081A2 Veterinary immunisation vectors comprising nucleic acid sequences encoding variants of non-human c3d polypeptides |
| 04/25/2002 | WO2002033080A2 Regulation of human netrin binding membrane receptor unc5h-1 |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033078A1 A novel-polypeptide, a proliferating cell antigen p120-51.59 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002033077A1 Novel polypeptide--- a regulatory protein 10.01 being related to human development and polynucleotide encoding it |
| 04/25/2002 | WO2002033076A1 Novel polypeptide - the eukaryotic transcript factor 17.38 and polynucleotide encoding it |
| 04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
| 04/25/2002 | WO2002033071A1 Survivin-like polypeptides and dnas thereof |
| 04/25/2002 | WO2002033067A2 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
| 04/25/2002 | WO2002033065A2 Method for producing proteins by electroporation |
| 04/25/2002 | WO2002033051A1 A plant autophagy gene |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002033046A2 Glucose transport-related genes and uses thereof |
| 04/25/2002 | WO2002032963A1 Immunoadjuvant systems |
| 04/25/2002 | WO2002032962A2 Compositions of human proteins and method of use thereof |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032959A2 Obesity-specific g protein coupled receptors |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032957A1 Peg-modified erythropoietin |
| 04/25/2002 | WO2002032956A2 Human cyclic nucleotide binding protein |
| 04/25/2002 | WO2002032955A1 Human gene critical to fertility |
| 04/25/2002 | WO2002032954A2 Phosphorylation modifications of apoptin |
| 04/25/2002 | WO2002032951A1 A novel polypeptide, a f-box protein 44.33 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002032949A1 A novel polypeptide-homo macro-protein 81 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032948A1 A novel polypeptide-homo macro-protein 10.12 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032947A1 Transgenic plants |
| 04/25/2002 | WO2002032946A2 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae |
| 04/25/2002 | WO2002032945A2 Haemophilus influenzae basb206 gene and protein |
| 04/25/2002 | WO2002032944A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032942A2 Compositions and methods for modulating rsv infection and immunity |
| 04/25/2002 | WO2002032941A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 04/25/2002 | WO2002032940A2 Osteopontin-coated surfaces and methods of use |
| 04/25/2002 | WO2002032939A2 Secreted proteins and their uses |
| 04/25/2002 | WO2002032938A2 Regulation of human pgc-1-like protein |
| 04/25/2002 | WO2002032937A2 Neuromedin u delta |
| 04/25/2002 | WO2002032936A2 E. histolytica-specific antibodies and clinical uses thereof |
| 04/25/2002 | WO2002032935A1 Immunoenzymatic quantification method |
| 04/25/2002 | WO2002032932A2 Urotensin-ii agonists and antagonists |
| 04/25/2002 | WO2002032931A2 Haplotypes of the fos gene |
| 04/25/2002 | WO2002032930A2 Haplotypes of the scya21 gene |
| 04/25/2002 | WO2002032929A2 Haplotypes of the cer1 gene |
| 04/25/2002 | WO2002032927A2 Haplotypes of the scya20 gene |
| 04/25/2002 | WO2002032925A2 Protein scaffolds for antibody mimics and other binding proteins |
| 04/25/2002 | WO2002032924A2 Haplotypes of the chrm5 gene |
| 04/25/2002 | WO2002032923A2 Improved formulations using heat shock/stress protein-peptide complexes |
| 04/25/2002 | WO2002032642A2 Electroprocessing polymers to form footwear and clothing |
| 04/25/2002 | WO2002032537A2 Improved method of expanded bed chromatography |
| 04/25/2002 | WO2002032463A1 Methods of treating cancers by stimulating dendritic cells or lymphomas with certain tnf molecules |
| 04/25/2002 | WO2002032453A1 Synthetic peptide hog cholera vaccine and method producing it |
| 04/25/2002 | WO2002032452A1 Composition for aids and method producing it |
| 04/25/2002 | WO2002032449A2 Method for treating ischemic events affecting the central nervous system |
| 04/25/2002 | WO2002032445A2 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | WO2002032288A2 Cd38 modulated chemotaxis |
| 04/25/2002 | WO2002032286A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2001098506A3 Methods and means for regulation of gene expression |
| 04/25/2002 | WO2001096873A3 Method for identifying apoptosis-modified proteins |